Kamdem S, Konhawa F, Kuemkon E, Meyo Kamguia L, Tchanana G, Nche F, et al. Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon. Front Immunol. 2019;10:2827 pubmed publisher

Segiet O, Romuk E, Nowalany Kozielska E, Wojciechowska C, Piecuch A, Wojnicz R. The concentration of interleukin-33 in heart failure with reduced ejection fraction. Anatol J Cardiol. 2019;21:305-313 pubmed publisher

Nasr W, Sorour S, El Bahrawy A, Boghdadi G, El Shahaway A. The Role of the Level of Interleukin-33 in the Therapeutic Outcomes of Immunotherapy in Patients with Allergic Rhinitis. Int Arch Otorhinolaryngol. 2018;22:152-156 pubmed publisher

Yang Y, Andersson P, Hosaka K, Zhang Y, Cao R, Iwamoto H, et al. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages. Nat Commun. 2016;7:11385 pubmed publisher

Hu W, Li M, Liu W, Jin L, Li D, Zhu X. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-?B and ERK1/2 signaling. Mol Hum Reprod. 2014;20:358-72 pubmed publisher

Hoeve M, Nash A, Jackson D, Randall R, Dransfield I. Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS ONE. 2012;7:e29443 pubmed publisher